Lupin slips 6% after USFDA classifies Somerset facility as OAI

The facility may be subject to regulatory or administrative action and the US FDA may withhold approval of any pending applications or supplements in which this facility is listed

from Latest News https://ift.tt/2HH61z5
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share